Generate a tailored SOP for Dr. David Kirn. Improve your application with a focused, well-structured draft.
David Kirn is an Adjunct Professor in the Department of Bioengineering at the University of California, Berkeley. As the CEO and Co-Founder of 4D Molecular Therapeutics, he is involved in advancing engineering techniques in molecular therapies. His research integrates principles of biology and engineering to develop innovative therapeutic solutions.
University of California, Berkeley • Berkeley, CA
Teaching and conducting research in the field of bioengineering.
4D Molecular Therapeutics •
Leading efforts to develop advanced molecular therapies.
The Mathematics Subject GRE is required for the Fall 2026 admissions cycle. General GRE is optional.